LobbyingMulticare Health System lobbying by quarter
Multicare Health System's latest lobbying report covers Q2 2026, at $40K. The four quarters Q3 2025–Q2 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Multicare Health System
- Latest quarter
- $40K
- Q2 2026 · 1 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
Policy issues the reports name
- Health issues15 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Federal Emergency Management Agency (FEMA)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| King & Spalding | $480K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| TODD TUTEN | Jan 2025-Mar 2026 U.S. Senate Committee on Health, Education, Labor, & Pensions, Chief Counsel May 2025-Mar 2026, Senior Health Counsel Jan 2025-May 2025 [House Lobbying Only] | Q2 2026 |
| SCOTT DZIENGELSKI | Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017) | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | King & Spalding | $40K |
| 04/20for Q1 | King & Spalding | $40K |
| 01/19for Q4 2025 | King & Spalding | $40K |
| 25/10/19for Q3 2025 | King & Spalding | $30K |
| 25/07/21for Q2 2025 | King & Spalding | $30K |
| 25/04/17for Q1 2025 | King & Spalding | $30K |
| 25/01/14for Q4 2024 | King & Spalding | $30K |
| 24/10/20for Q3 2024 | King & Spalding | $30K |
| 24/07/21for Q2 2024 | King & Spalding | $30K |
| 24/04/19for Q1 2024 | King & Spalding | $30K |
| 24/01/15for Q4 2023 | King & Spalding | $30K |
| 23/10/16for Q3 2023 | King & Spalding | $30K |
| 23/07/11for Q2 2023 | King & Spalding | $30K |
| 23/04/18for Q1 2023 | King & Spalding | $30K |
| 23/01/18for Q4 2022 | King & Spalding | $30K |